Improved Commercial Land for Sale in Hammonton, New Jersey

Family owned and operated contract Medical Device Manufacturer located in Atlantic County, NJ, specializing in traditional Xeroform, Oil Emulsion, and Petrolatum wound care dressings. Located on close to 4 acres with over 31,000 SF of manufacturing, office and warehouse space with approved plans to expand with another 4,000+ SF. The property includes ample parking to accommodate the required number of employees to operate the business. Annual Property Taxes are approximately $27,000. Facilities are well maintained and the business generates stable gross revenues and net profits that justify the sales price. Business inventory and work in progress along with specialized custom manufacturing equipment and quality control systems all included in the sale. The management team and key subject matter experts are willing to stay on board for a transition and training period.

Management team has over 50 years of combined experience in the medical device industry. This includes well-respected names in Manufacturing, Regulatory Affairs, Quality Assurance, Sales and Marketing. The company's core management team has been manufacturing these products since the 1980s. The products are used in hospitals, clinics, outpatient surgery centers, nursing homes, physician's offices and in-home healthcare settings. The company's product line includes a full line of impregnated wound care dressings including Xeroform, Petrolatum, and Oil Emulsion Gauze (Adaptic), Plain and Iodoform Packing Strips. The company has an outstanding Quality Control system in place, ensuring that they produce a high quality product for their customers. The business has passed numerous government (FDA) and private audits to ensure compliance with the industry they serve.

Detailed information that includes business financials, inventory, equipment, work in progress, facility expansion application and development plan and other pertinent and proprietary information will be shared with interested buyers/investors only after proof of funds are provided and Non Disclosure Agreement (NDA) is signed.